09/2009 - Državni zavod za intelektualno vlasništvo

HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 16, 2009, 9, 3373 – 3601 3545
Podnositelj europske MKP Broj objave europske Naziv izuma
prijave patenta
prijave patenta
(71) (51) (97) (54)
Bristol-Myers Squibb Company, US C07K 5/08 (2006.01)
EP 2086995 * HEPATITIS C VIRUS INHIBITORS
A61K 31/401 (2006.01)
A61P 31/00 (2006.01)
Bristol-Myers Squibb Company, US A61K 31/407 (2006.01)
C07D 487/04 (2006.01)
EP 2089020 *
C07D 498/04 (2006.01)
A61P 31/12 (2006.01)
Bristol-Myers Squibb Company, US C07D 213/82 (2006.01)
A61K 31/444 (2006.01)
A61P 35/00 (2006.01)
Bristol-Myers Squibb Company, US C07D 409/04 (2006.01)
C07D 231/56 (2006.01)
C07D 237/32 (2006.01)
C07D 239/88 (2006.01)
C07D 487/04 (2006.01)
C07D 495/04 (2006.01)
C07D 498/04 (2006.01)
Bristol-Myers Squibb Company, US C07C 211/48 (2006.01)
C07C 215/20 (2006.01)
C07C 233/18 (2006.01)
C07C 275/08 (2006.01)
C07C 275/18 (2006.01)
C07C 275/26 (2006.01)
C07D 213/61 (2006.01)
C07D 307/32 (2006.01)
C07D 309/14 (2006.01)
A61K 31/44 (2006.01)
A61K 31/165 (2006.01)
A61K 31/17 (2006.01)
A61K 31/137 (2006.01)
A61P 3/06 (2006.01)
A61P 3/04 (2006.01)
Bristol-Myers Squibb Company, US C07D 487/04 (2006.01)
A61K 31/5025 (2006.01)
A61P 3/04 (2006.01)
A61P 25/04 (2006.01)
Bristol-Myers Squibb Company, US C07D 231/56 (2006.01)
C07D 401/12 (2006.01)
C07D 403/12 (2006.01)
C07D 409/12 (2006.01)
A61K 31/416 (2006.01)
A61P 29/02 (2006.01)
Bristol-Myers Squibb Company, US C07D 401/04 (2006.01)
A61K 31/4155 (2006.01)
A61P 29/00 (2006.01)
Bristol-Myers Squibb Company, US C07D 417/14 (2006.01)
Bunge Oils, Inc, US C11C 3/10 (2006.01)
B01J 8/02 (2006.01)
C12N 11/18 (2006.01)
C11C 1/08 (2006.01)
BYK-Chemie GmbH, DE C01B 31/02 (2006.01)
Cadila Healthcare Limited, IN C07D 495/04 (2006.01)
Cadila Healthcare Limited, IN A61K 9/19 (2006.01)
A61K 47/12 (2006.01)
A61K 38/21 (2006.01)
Cadila Healthcare Limited, IN C07D 223/16 (2006.01)
C07C 217/56 (2006.01)
Cegnar, Erik J., US H02J 1/00 (2006.01)
H02J 7/00 (2006.01)
CENTELION, FR C12N 15/62 (2006.01)
A61K 38/17 (2006.01)
A61K 47/48 (2006.01)
C07K 14/47 (2006.01)
C07K 14/71 (2006.01)
Centocor Ortho Biotech Inc., US C12N 5/16 (2006.01)
Centre de Recherche Publique de la
Santé (CRP-Santé), LU
C12N 15/02 (2006.01)
A61K 31/352 (2006.01)
A61K 31/41 (2006.01)
A61K 31/4196 (2006.01)
A61K 31/519 (2006.01)
A61K 31/7105 (2006.01)
A61P 9/04 (2006.01)
A61K 31/7088 (2006.01)
A61K 38/00 (2006.01)
EP 2089364 *
EP 2089385 *
EP 2094643 *
EP 2094705 *
EP 2099767 *
EP 2099779 *
EP 2099794 *
EP 2094824 *
EP 2089317 *
EP 2089396 *
EP 2097068 *
EP 2097383 *
EP 2089947 *
EP 2092069 *
EP 2087102 *
EP 2086533 *
MACROCYCLIC PEPTIDES AS HEPATITIS C VIRUS
INHIBITORS
PYRIDINONE COMPOUNDS
INHIBITORS OF HEPATITIS C VIRUS
Centro De Ingenieria Genetica Y C07K 16/22 (2006.01)
EP 2093236 *
Biotecnologia, CU
CERA Handelsgesellschaft mbH, DE E06B 3/667 (2006.01) EP 2045433 U-shaped connector
N-((3-BENZYL)-2,2-(BIS-PHENYL)-PROPAN-1-AMINE
DERIVATIVES AS CETP INHIBITORS FOR THE
TREATMENT OF ATHEROSCLEROSIS AND
CARDIOVASCULAR DISEASES
AZABICYCLIC HETEROCYCLES AS CANNABINOID
RECEPTOR MODULATORS
MODULATORS OF GLUCOCORTICOID RECEPTOR,
AP-1, AND/OR NF- B ACTIVITY AND USE THEREOF
CRYSTALLINE FORMS OF ARYL-SUBSTITUTED
PYRAZOLE-AMIDE COMPOUNDS
THIAZOLYL COMPOUNDS USEFUL AS KINASE
INHIBITORS
A CONTINUOUS PROCESS AND APPARATUS FOR
ENZYMATIC TREATMENT OF LIPIDS
DISPERSION METHOD
A PROCESS FOR PREPARING (S)-(+)-
CLOPIDOGREL BASE AND ITS SALTS
FORMULATIONS OF PEG-INTERFERON ALPHA
CONJUGATES
PROCESS FOR PREPARATION OF IVABRADINE
HYDROCHLORIDE
ULTRA-FAST ULTRACAPACITOR PACK/DEVICE
CHARGER
MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS
WITH IMPROVED BIOLOGICAL ACTIVITY
ENHANCEMENT OF HYBRIDOMA FUSION
EFFICIENCIES THROUGH CELL SYNCHRONIZATION
USE OF AN ADENOSINE ANTAGONIST
RECOMBINANT ANTIBODIES AGAINST VASCULAR
ENDOTHELIAL GROWTH FACTOR (VEGF)
ISSN 1331-2030